Cargando…

Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis

Obstructive sleep apnoea (OSA) is characterized by frequent apnoea episodes during sleep due to upper airway obstruction. The present review summarizes current knowledge on inter-relationships between OSA and type 2 diabetes mellitus (T2DM) and suggests the former as a possible target for sodium-glu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monda, Vincenzo Maria, Porcellati, Francesca, Strollo, Felice, Fucili, Alessandro, Monesi, Marcello, Satta, Ersilia, Gentile, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342338/ https://www.ncbi.nlm.nih.gov/pubmed/34273093 http://dx.doi.org/10.1007/s12325-021-01791-x

Ejemplares similares

Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
por: Monda, Vincenzo Maria, et al.
Publicado: (2022)

Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy
por: Monda, Vincenzo M., et al.
Publicado: (2023)

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
por: Monda, Vincenzo M., et al.
Publicado: (2020)

Effect of Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD
por: Guarino, Giuseppina, et al.
Publicado: (2023)

Gliflozine – in Zukunft Kardioprotektiva?
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2021)

Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
por: Gentile, Sandro, et al.
Publicado: (2019)

Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)

The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study
por: Gentile, Sandro, et al.
Publicado: (2021)

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021)

Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?
por: Heyman, Samuel N., et al.
Publicado: (2023)

Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey
por: Gentile, Sandro, et al.
Publicado: (2021)

Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case–Control Study
por: Gentile, Sandro, et al.
Publicado: (2021)

Free Triiodothyronine and Cholesterol Levels in Euthyroid Elderly T2DM Patients
por: Strollo, F., et al.
Publicado: (2012)

Therapy of Type 2 diabetes: more gliflozines and less metformin?
por: Verdecchia, Paolo, et al.
Publicado: (2023)

Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
por: Strollo, Felice, et al.
Publicado: (2017)

Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes
por: Bragagni, Alessio, et al.
Publicado: (2021)

Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
por: Gentile, Sandro, et al.
Publicado: (2016)

COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
por: Gentile, Sandro, et al.
Publicado: (2020)

Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy
por: Gentile, Sandro, et al.
Publicado: (2020)

The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
por: Gentile, Sandro, et al.
Publicado: (2020)

Recent Progress in Space Physiology and Aging
por: Strollo, Felice, et al.
Publicado: (2018)

Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective
por: de Pouvourville, Gérard, et al.
Publicado: (2023)

Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice
por: Cesaro, Arturo, et al.
Publicado: (2023)

The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study
por: Gentile, Sandro, et al.
Publicado: (2022)

Correction to: The Economic Burden of Insulin Injection-Induced Lipohypertrophy. Role of Education: The ISTERP-3 Study
por: Gentile, Sandro, et al.
Publicado: (2022)

Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?
por: Gentile, Sandro, et al.
Publicado: (2022)

SAVOR-TIMI to DECLARE-TIMI: A Review on Cardiovascular Outcome Trials of Incretin-modulators and Gliflozins
por: Singh, Awadhesh K., et al.
Publicado: (2019)

Gliflozins for the prevention of stroke in diabetes and cardiorenal diseases: A meta-analysis of cardiovascular outcome trials
por: Zhao, Li-Min, et al.
Publicado: (2021)

The Role of Aldosterone in OSA and OSA-Related Hypertension
por: Wang, Yi, et al.
Publicado: (2022)

Meta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials
por: Yin, Daogen, et al.
Publicado: (2021)

Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
por: Correale, Michele, et al.
Publicado: (2023)

Metabolism and Chemical Degradation of New Antidiabetic Drugs: A Review of Analytical Approaches for Analysis of Glutides and Gliflozins
por: Gumieniczek, Anna, et al.
Publicado: (2023)

A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
por: Patorno, Elisabetta, et al.
Publicado: (2018)

The association between dysphagia and OSA
por: Marra, Lorenzo, et al.
Publicado: (2022)

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

Gliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In Vitro
por: Koch, Benjamin, et al.
Publicado: (2023)

P085 OSA-Onset: An algorithm for predicting the age of OSA onset
por: Olaithe, M, et al.
Publicado: (2022)

Nasal resistance and OSA
por: Neto, Levon Mekhitarian
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mn053p6sen2fc7qg263fp4afpm